Stock listing
Neurizon Therapeutics Limited
Selected listing: A40STF · LS · EUR · DE
Neurizon Therapeutics Limited (Lang & Schwarz: A40STF), Health Technology. Latest release Oct 5, 2026: FDA Type C Feedback, HEALEY trial potentially…
- Ticker
- Lang & Schwarz: A40STF
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
About Neurizon Therapeutics Limited
The company is focused on developing innovative therapeutic solutions. Neurizon aims to address unmet medical needs through its research and development efforts.
Latest news from Neurizon Therapeutics Limited
FDA Type C Feedback, HEALEY trial potentially registrational
October 5, 2026
Neurizon Announces Partial Redemption of Convertible Notes
September 9, 2026
NIH funds Expanded Access Program for NUZ-001 in ALS
September 8, 2026
Neurizon Appoints Chief Executive Officer
September 6, 2026
Appendix 4E and 2026 Annual Report
August 25, 2026
Research Neurizon Therapeutics Limited
Neurizon Therapeutics Limited company profile
View the public company page for Neurizon Therapeutics Limited on 6ix.
Neurizon Therapeutics Limited news
Read company news and market updates connected to Neurizon Therapeutics Limited.
Neurizon Therapeutics Limited investor events
Find investor webinars, events, and replay context for Neurizon Therapeutics Limited.
Alternate listings
NUZ:ASX
AU · AUD
Alternate listing for Neurizon Therapeutics Limited; the primary context on this page is A40STF:LS.
A40STF:LSX
DE · EUR
Alternate listing for Neurizon Therapeutics Limited; the primary context on this page is A40STF:LS.
A0DNJ3:LSX
DE · EUR
Alternate listing for Neurizon Therapeutics Limited; the primary context on this page is A40STF:LS.
ECQ0:FWB
DE · EUR
Alternate listing for Neurizon Therapeutics Limited; the primary context on this page is A40STF:LS.
A0DNJ3:LS
DE · EUR
Alternate listing for Neurizon Therapeutics Limited; the primary context on this page is A40STF:LS.
NUZTF:OTC
US · USD
Alternate listing for Neurizon Therapeutics Limited; the primary context on this page is A40STF:LS.
ECQ0:SWB
DE · EUR
Alternate listing for Neurizon Therapeutics Limited; the primary context on this page is A40STF:LS.